Citation: | ZHAO Yili, LIANG Linlin, HE Xiaoshuang, HENG Weili, PANG Zunting, QIAN Shuai, GAO Yuan, ZHANG Jianjun, WEI Yuanfeng. Crystallization transformation of amorphous extracts of traditional Chinese medicine and its effect on dissolution behavior — Taking total flavonoids from Pueraria lobata as an example[J]. Journal of China Pharmaceutical University, 2023, 54(1): 68-76. DOI: 10.11665/j.issn.1000-5048.20221124002 |
[1] |
. Chin Tradit Herb Drugs(中草药),2008,39(6):932-934.
|
[2] |
Zhao Q,Luan X,Zheng M,et al. Synergistic mechanisms of constituents in herbal extracts during intestinal absorption:focus on natural occurring nanoparticles[J]. Pharmaceutics,2020,12(2):128.
|
[3] |
Grooff D,Liebenberg W,De Villiers MM. Preparation and transformation of true nifedipine polymorphs:investigated with differential scanning calorimetry and X-ray diffraction pattern fitting methods[J]. J Pharm Sci,2011,100(5):1944-1957.
|
[4] |
Jha DK,Shah DS,Amin PD. Thermodynamic aspects of the preparation of amorphous solid dispersions of Naringenin with enhanced dissolution rate[J]. Int J Pharm,2020,583:119363.
|
[5] |
Shuai SP,Yue SL,Huang QT,et al. Preparation,characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability[J]. Eur J Drug MeTable Pharmacokinet,2016,41(4):413-422.
|
[6] |
Kumar S,Shen J,Burgess DJ. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole[J]. J Control Release,2014,192:95-102.
|
[7] |
Shi Q,Cai T. Recent progress on crystallizations of amorphous pharmaceutical solids[J]. J China Pharm Univ(中国药科大学学报),2017,48(6):654-662.
|
[8] |
Zhang YZ,Yao J,Yin DD,et al. Properties and dissolution in vitro of indomethacin Soluplus amorphous preparation[J]. Chin J New Drugs(中国新药杂志),2016,25(7):830-835.
|
[9] |
Grzybowska K,Paluch M,Grzybowski A,et al. Molecular dynamics and physical stability of amorphous anti-inflammatory drug:celecoxib[J]. J Phys Chem B,2010,114(40):12792-12801.
|
[10] |
Qian S,Heng WL,Wei YF,et al. Coamorphous lurasidone hydrochloride-saccharin with charge-assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior[J]. Cryst Growth Des,2015,15(6):2920-2928.
|
[11] |
Song W,Li YJ,Qiao X,et al. Chemistry of the Chinese herbal medicine Puerariae radix (Ge-Gen):a review[J]. J Chin Pharm Sci,2014,23(6):347-360.
|
[12] |
Mu PP,An Q,Zhang YZ,et al. Determination of 9 isoflavonoids in Puerariae Lobatae Radix with quantitative analysis of multi-components by single marker[J]. China J Chin Mater Med(中国中药杂志),2019,44(22):4888-4895.
|
[13] |
Zhang SS,Zhang NN,Guo S,et al. Glycosides and flavonoids from the extract of Pueraria thomsonii Benth leaf alleviate type 2 diabetes in high-fat diet plus streptozotocin-induced mice by modulating the gut microbiota[J]. Food Funct,2022,13(7):3931-3945.
|
[14] |
Zhang Z,Lam TN,Zuo Z. Radix Puerariae:an overview of its chemistry,pharmacology,pharmacokinetics,and clinical use[J]. J Clin Pharmacol,2013,53(8):787-811.
|
[15] |
Chen ZM,Huang Y,Guo YY,et al. Extraction and purification of Radix Pueraria total flavonoids and determination method of favonoids content[J]. China Pharm(中国药业),2014,23(3):22-24.
|
[16] |
Pei LX,Ji BY,Chen SQ. Study on dynamic changes of total flavonoids content of Radix Puerariae in different harvest times[J]. China Med Her(中国医药导报),2017,14(19):28-30.
|
[17] |
Lu DY,Kang S,Zhao YZ,et al. Study on Ranunculaceae herbal decoction pieces using X-ray diffraction[J]. China J Chin Mater Med(中国中药杂志),2019,44(3):482-488.
|
[18] |
Zhu WF,Li JL,Meng XW,et al. Research advances in chemical constituents and pharmacological activities of Pueraria genus[J]. China J Chin Mater Med(中国中药杂志),2021,46(6):1311-1331.
|
[19] |
Yu X,Kappes SM,Bello-Perez LA,et al. Investigating the moisture sorption behavior of amorphous sucrose using a dynamic humidity generating instrument[J]. J Food Sci,2008,73(1):E25-E35.
|
[20] |
Xie T,Taylor LS. Effect of temperature and moisture on the physical stability of binary and ternary amorphous solid dispersions of celecoxib[J]. J Pharm Sci,2017,106(1):100-110.
|
[21] |
Luo MQ,Heng WL,Dai J,et al. Crystallization of amorphous drugs and inhibiting strategies[J]. Prog Chem(化学进展),2021,33(11):2116-2127.
|
[22] |
Yan MM,Wu XJ,Zhu HQ,et al. Optimization and screening of carrier for solid dispersion of olaparib based on the solubility parameter and differential scanning calorimetry[J]. Acta Pharm Sin(药学学报),2022,57(5):1486-1494.
|